The plasminogen activator system modulates sympathetic nerve function
Open Access
- 28 August 2006
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 203 (9) , 2191-2200
Abstract
Sympathetic neurons synthesize and release tissue plasminogen activator (t-PA). We investigated whether t-PA modulates sympathetic activity. t-PA inhibition markedly reduced contraction of the guinea pig vas deferens to electrical field stimulation (EFS) and norepinephrine (NE) exocytosis from cardiac synaptosomes. Recombinant t-PA (rt-PA) induced exocytotic and carrier-mediated NE release from cardiac synaptosomes and cultured neuroblastoma cells; this was a plasmin-independent effect but was potentiated by a fibrinogen cleavage product. Notably, hearts from t-PA–null mice released much less NE upon EFS than their wild-type (WT) controls (i.e., a 76.5% decrease; P < 0.01), whereas hearts from plasminogen activator inhibitor-1 (PAI-1)–null mice released much more NE (i.e., a 275% increase; P < 0.05). Furthermore, vasa deferentia from t-PA–null mice were hyporesponsive to EFS (P < 0.0001) but were normalized by the addition of rt-PA. In contrast, vasa from PAI-1–null mice were much more responsive (P < 0.05). Coronary NE overflow from hearts subjected to ischemia/reperfusion was much smaller in t-PA–null than in WT control mice (P < 0.01). Furthermore, reperfusion arrhythmias were significantly reduced (P < 0.05) in t-PA–null hearts. Thus, t-PA enhances NE release from sympathetic nerves and contributes to cardiac arrhythmias in ischemia/reperfusion. Because the risk of arrhythmias and sudden cardiac death is increased in hyperadrenergic conditions, targeting the NE-releasing effect of t-PA may have valuable therapeutic potential.Keywords
This publication has 69 references indexed in Scilit:
- Tissue-Type Plasminogen Activator Crosses the Intact Blood-Brain Barrier by Low-Density Lipoprotein Receptor–Related Protein-Mediated TranscytosisCirculation, 2005
- Structure and function of the plasminogen/plasmin systemThrombosis and Haemostasis, 2005
- Coupling of angiotensin II AT1receptors to neuronal NHE activity and carrier-mediated norepinephrine release in myocardial ischemiaAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Ectonucleotidase in Sympathetic Nerve Endings Modulates ATP and Norepinephrine Exocytosis in Myocardial IschemiaThe Journal of Pharmacology and Experimental Therapeutics, 2003
- The use of the human neuroblastoma SH-SY5Y to study the effect of second messengers on noradrenaline releaseGeneral Pharmacology: The Vascular System, 1995
- Plasminogen Activator Expression in Human Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Role of sympathetic cholinergic pathway in the neurogenous control of tissue-type plasminogen activator release into the bloodBlood Coagulation & Fibrinolysis, 1993
- Modulation of Proteolytic Activity During Neuritogenesis in the PC12 Nerve Cell: Differential Control of Plasminogen Activator and Plasminogen Activator Inhibitor Activities by Nerve Growth Factor and Dibutyryl‐Cyclic AMPJournal of Neurochemistry, 1991
- Associated reactions during and immediately after rtPA infusionAnnals of Emergency Medicine, 1989
- Effects of acidosis on anoxic and exocytotic noradrenaline release from the heartJournal of Molecular and Cellular Cardiology, 1989